Data / Federal grants / HT942526VRPCTA
DoW Vision, Clinical Trial Award
Defense Health Agency Contracting Activity - DHACA (Department of Defense) is accepting applications until November 12, 2026. It lists 1 award expected, $2.6 million in total.
SpecStream is the live web data engine for teams and agents. It reads every open and forecast federal opportunity on Grants.gov each morning, and this page is that reading. Describe your organization once and the grants that fit arrive in your sheet, CRM, Slack or agent as they are posted.
Key facts
- Opportunity number
- HT942526VRPCTA
- Status
- Posted, open
- Posted
- May 5, 2026
- Closes
- November 12, 2026
- Expected awards
- 1
- Total funding
- $2,600,000
- Cost sharing
- Not required
- Funding instrument
- Grant
- Category
- Science and Technology and other Research and Development
- Assistance listing
- 12.420 Military Medical Research and Development
- Contact
- Teresa M Parker-Reeser Grants Officer · [email protected] · 3016192171
Who can apply
- Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"
What the agency says
Summary: The fiscal year 2026 (FY26) Vision Research Program (VRP) Clinical Trial Award (CTA) supports the rapid implementation of clinical trials with the potential to have a significant impact on the treatment or management of service-connected eye injury and visual dysfunction. Research must align with at least one of the FY26 VRP Focus Areas .
Distinctive Features:
· For interventions that require Investigational New Drug (IND)/Investigational Device Exemption (IDE) or equivalent regulatory authorizations for clinical testing, the IND/IDE application or equivalent must be submitted to the relevant Regulatory Agency by the CTA application submission deadline. In addition, applicants must provide documentation of communication from the Regulatory Agency indicating that the IND/IDE or equivalent is active/safe to proceed by March 1, 2027, in order for the CTA application to be considered for funding. Refer to Attachment 7: Regulatory Strategy for further details.
· Scored peer review criteria include Clinical Impact; Research Strategy and Feasibility; Recruitment, Accrual, Retention; Regulatory Strategy and Transition Plan; Statistical Plan and Data Analysis; Ethical Considerations; Personnel and Communication.
· Programmatic review criteria include adherence to the intent of the CTA, contribution to program portfolio, relative impact and relevance to military health.
https://cdmrp.health.mil/pubs/press/2026/vrppreann
Other open grants from the Department of Defense
| Opportunity | Status | Closes | Award ceiling | Total funding | Record |
|---|---|---|---|---|---|
| ONR FY27 NOFO for Young Investigator Program N0001426SF004 | Open | Oct 30 | grants.gov | ||
| DoW Bone Marrow Failure, Idea Development Award HT942526BMFRPIDA | Open | Nov 4 | $4,000,000 | grants.gov | |
| DoW Bone Marrow Failure, Investigator-Initiated Research Award HT942526BMFRPIIRA | Open | Nov 4 | $1,250,000 | grants.gov | |
| DoW Bone Marrow Failure, Resource Development Award HT942526BMFRPRDA | Open | Nov 4 | $1,250,000 | grants.gov | |
| DoW Reconstructive Transplant, Concept Award HT942526RTRPCA | Open | Nov 4 | $600,000 | grants.gov | |
| DoW Reconstructive Transplant, Investigator-Initiated Research Award HT942526RTRPIIRA | Open | Nov 4 | $8,000,000 | grants.gov |
All grants open to Anyone (unrestricted) · Everything closing in November 2026
Read from the Grants.gov API, last updated 2026-10-23. The agency's notice on Grants.gov is the official record; check it before you apply.